Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleResearch Article

Short–term Intensive Neoadjuvant Chemotherapy Improving 10–year Survival for Patients with Stage II and Operable Stage III Breast Cancer

Bin Zhang, Yue Cai, Qi Zhang, Ziwei Ying, Shuling Jiang, Hong Xu, Yongxue Zheng and Daqing Jiang
Chinese Journal of Clinical Oncology February 2004, 1 (1) 42-46;
Bin Zhang
Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Cai
Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qi Zhang
Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziwei Ying
Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuling Jiang
Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Xu
Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongxue Zheng
Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daqing Jiang
Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 1 no. 1 42-46

Published By 
Cancer Biology & Medicine
History 
  • Received January 11, 2004
  • Accepted March 22, 2004
  • Published online February 1, 2004.

Copyright & Usage 
Copyright © 2004 by Tianjin Medical University Cancer Institute & Hospital and Springer

Author Information

  1. Bin Zhang
  1. Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  1. Yue Cai
  1. Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  1. Qi Zhang
  1. Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  1. Ziwei Ying
  1. Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  1. Shuling Jiang
  1. Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  1. Hong Xu
  1. Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  1. Yongxue Zheng
  1. Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
  1. Daqing Jiang
  1. Department of Breast Cancer, Liaoning Province Tumor Hospital, Shenyang 110042, China.
View Full Text
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 1 (1)
Chinese Journal of Clinical Oncology
Vol. 1, Issue 1
1 Feb 2004
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Short–term Intensive Neoadjuvant Chemotherapy Improving 10–year Survival for Patients with Stage II and Operable Stage III Breast Cancer
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Short–term Intensive Neoadjuvant Chemotherapy Improving 10–year Survival for Patients with Stage II and Operable Stage III Breast Cancer
Bin Zhang, Yue Cai, Qi Zhang, Ziwei Ying, Shuling Jiang, Hong Xu, Yongxue Zheng, Daqing Jiang
Chinese Journal of Clinical Oncology Feb 2004, 1 (1) 42-46;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Short–term Intensive Neoadjuvant Chemotherapy Improving 10–year Survival for Patients with Stage II and Operable Stage III Breast Cancer
Bin Zhang, Yue Cai, Qi Zhang, Ziwei Ying, Shuling Jiang, Hong Xu, Yongxue Zheng, Daqing Jiang
Chinese Journal of Clinical Oncology Feb 2004, 1 (1) 42-46;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Changing Paradigms in Clinical Oncology Research — Highlights from the 2011 ASCO Annual Meeting and Beyond
  • B7-H4 Expression and Increased Death Risk of Cancer Patients: A Meta-Analysis
  • Efficacy and Immune Mechanisms of Cetuximab for the Treatment of Metastatic Colorectal Cancer
Show more Research Article

Similar Articles

Keywords

  • breast cancer
  • stage II
  • III
  • control study
  • neoadjuvant chemotherapy
  • 10–year follow-up

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire